1. NF-κB Apoptosis Immunology/Inflammation Metabolic Enzyme/Protease Stem Cell/Wnt MAPK/ERK Pathway
  2. NF-κB Apoptosis COX HIF/HIF Prolyl-Hydroxylase Wnt β-catenin JNK
  3. Dendrophenol

Dendrophenol  (Synonyms: Moscatilin)

Cat. No.: HY-N6031 Purity: 99.88%
SDS COA Handling Instructions

Dendrophenol (Moscatilin) is a NF-κB inhibitor that inhibits inflammation. Dendrophenol exerts potent cytotoxic effect against tumor cells and induces cell cycle arrest and apoptosis. Dendrophenol has antitumor activity. In addition, Dendrophenol can inhibit vascular calcification.

For research use only. We do not sell to patients.

Dendrophenol Chemical Structure

Dendrophenol Chemical Structure

CAS No. : 108853-14-1

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

View All COX Isoform Specific Products:

View All HIF/HIF Prolyl-Hydroxylase Isoform Specific Products:

View All JNK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Dendrophenol (Moscatilin) is a NF-κB inhibitor that inhibits inflammation. Dendrophenol exerts potent cytotoxic effect against tumor cells and induces cell cycle arrest and apoptosis. Dendrophenol has antitumor activity. In addition, Dendrophenol can inhibit vascular calcification[1][2][3][4].

IC50 & Target[1]

NF-κB

 

COX-2

 

HIF-1α

 

Cellular Effect
Cell Line Type Value Description References
A549 IC50
2.1 μM
Compound: 23MST; MST
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 72 hrs by MTT assay
[PMID: 31047774]
FaDu IC50
2.55 μM
Compound: 1
Cytotoxicity against human FaDu cells assessed as cell viability incubated for 24 hrs by CCK-8 assay
Cytotoxicity against human FaDu cells assessed as cell viability incubated for 24 hrs by CCK-8 assay
[PMID: 32711292]
HCCLM3 IC50
2.092 μM
Compound: 24
Antiproliferative activity against human HCCLM3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human HCCLM3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
[PMID: 34931827]
HCT-116 IC50
2.29 μM
Compound: 23MST; MST
Antiproliferative activity against human HCT116 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT116 cells incubated for 72 hrs by MTT assay
[PMID: 31047774]
HepG2 IC50
3.02 μM
Compound: 24
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
[PMID: 34931827]
HepG2 IC50
3.76 μM
Compound: 23MST; MST
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells incubated for 72 hrs by MTT assay
[PMID: 31047774]
MDA-MB-231 IC50
0.082 μM
Compound: 23MST; MST
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 72 hrs by MTT assay
[PMID: 31047774]
MKN-45 IC50
3.51 μM
Compound: 23MST; MST
Antiproliferative activity against human MKN45 cells incubated for 72 hrs by MTT assay
Antiproliferative activity against human MKN45 cells incubated for 72 hrs by MTT assay
[PMID: 31047774]
N2a IC50
> 20 μM
Compound: Mos
Cytotoxicity against mouse Neuro2a cells assessed as reduction in cell viability after 12 hrs by MTT assay
Cytotoxicity against mouse Neuro2a cells assessed as reduction in cell viability after 12 hrs by MTT assay
[PMID: 31291099]
N2a IC50
> 20 μM
Compound: Mos
Cytotoxicity against mouse Neuro2a cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against mouse Neuro2a cells assessed as reduction in cell viability after 24 hrs by MTT assay
[PMID: 31291099]
Platelet IC50
61.8 μM
Compound: 1
Antiplatelet activity against washed rabbit platelet assessed as inhibition of arachidonic acid-induced platelet aggregation preincubated for 3 mins by turbidimetric method
Antiplatelet activity against washed rabbit platelet assessed as inhibition of arachidonic acid-induced platelet aggregation preincubated for 3 mins by turbidimetric method
[PMID: 7798962]
RAW264.7 IC50
4.4 μM
Compound: 1
Cytotoxicity against mouse RAW264.7 cells assessed as decrease in cell proliferation rate after 24 hrs by MTS assay
Cytotoxicity against mouse RAW264.7 cells assessed as decrease in cell proliferation rate after 24 hrs by MTS assay
[PMID: 27777005]
SH-SY5Y IC50
> 20 μM
Compound: Mos
Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 12 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 12 hrs by MTT assay
[PMID: 31291099]
SH-SY5Y IC50
> 20 μM
Compound: Mos
Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 24 hrs by MTT assay
Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 24 hrs by MTT assay
[PMID: 31291099]
In Vitro

Dendrophenol (5-100 μM; 1 h) inhibits the expression of COX-2, iNOS, HIF-1α and NF-κB and inhibits cell activation in LPS (HY-D1056) treated macrophages[1].
Dendrophenol (0-50 μM; 15 h-6 days) exerts potent cytotoxic effect against tumor cell lines from placenta, lung and stomach, and can cause cell G2 phase arrest[2].
Dendrophenol (1 μM; 4 days) reduces calcium deposition via the WNT3/β-catenin pathway and reduces calcification induced inflammation by IL13RA2 and STAT3 in Phosphate-treated human aortic smooth muscle cells[3].
Dendrophenol (3-30 μM; 24 h) induces apoptosis of human colon cancer cell HCT-116 by tubulin depolymerization, DNA damage stress and JNK signaling pathway[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: LPS (HY-D1056) treated RAW264.7 cells
Concentration: 10, 30, 50 and 100 μM
Incubation Time: 1 h
Result: Inhibited the levels of COX-2 and iNOS in a concentration‐dependent manner.

Western Blot Analysis[3]

Cell Line: Phosphate treated HASMCs
Concentration: 1 μM
Incubation Time: 4 days
Result: Reduced the levels of WNT3 and β-catenin.
Increased the level of IL13RA2.
Reduced the levels of p-STAT3, IL-1β and IL-6.

Western Blot Analysis[4]

Cell Line: HCT-116 cells
Concentration: 3, 10 and 30 μM
Incubation Time: 24 h
Result: Increased the phosphorylation level of JNK1/2.
In Vivo

Dendrophenol (10 mg/kg; intraperitoneal injection; 3 weeks) has a beneficial effect in the mouse model of vascular calcification[3].
Dendrophenol (50-100 mg/kg; intraperitoneal injection; 5 times a week for 2 weeks) has antitumor effect in mouse tumor model[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Nicotine and Vitamin D3 (HY-15398) treated male C57BL/6J mice aged 25 weeks old[3]
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.); 3 weeks
Result: Reduced calcium accumulation in the thoracic aorta and aortic valves of the mice.
Reduced the expression of calcification-related genes, such as ALPL, BMP2 and RUNX2.
Animal Model: HCT-116 cells treated male severe combined immunodeficient mice[4]
Dosage: 50 and 100 mg/kg
Administration: Intraperitoneal injection (i.p.); five times a week for two weeks
Result: Significantly inhibited tumor growth and did not result in weight loss.
Molecular Weight

304.34

Formula

C17H20O5

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

COC1=C(O)C=CC(CCC2=CC(OC)=C(O)C(OC)=C2)=C1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : ≥ 61 mg/mL (200.43 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.2858 mL 16.4290 mL 32.8580 mL
5 mM 0.6572 mL 3.2858 mL 6.5716 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (8.21 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.21 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.88%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.2858 mL 16.4290 mL 32.8580 mL 82.1450 mL
5 mM 0.6572 mL 3.2858 mL 6.5716 mL 16.4290 mL
10 mM 0.3286 mL 1.6429 mL 3.2858 mL 8.2145 mL
15 mM 0.2191 mL 1.0953 mL 2.1905 mL 5.4763 mL
20 mM 0.1643 mL 0.8214 mL 1.6429 mL 4.1072 mL
25 mM 0.1314 mL 0.6572 mL 1.3143 mL 3.2858 mL
30 mM 0.1095 mL 0.5476 mL 1.0953 mL 2.7382 mL
40 mM 0.0821 mL 0.4107 mL 0.8214 mL 2.0536 mL
50 mM 0.0657 mL 0.3286 mL 0.6572 mL 1.6429 mL
60 mM 0.0548 mL 0.2738 mL 0.5476 mL 1.3691 mL
80 mM 0.0411 mL 0.2054 mL 0.4107 mL 1.0268 mL
100 mM 0.0329 mL 0.1643 mL 0.3286 mL 0.8214 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Dendrophenol
Cat. No.:
HY-N6031
Quantity:
MCE Japan Authorized Agent: